Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab

Published:2022-03-28 Issue:1 Volume:27 Page:384-395
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Hirata Akie¹²,Miyashita Kaname³^ORCID,Tanaka Takafumi³,Hirata Kiyoko⁴,Narazaki Taisuke³,Utsunomiya Hayato⁴,Ohno Hirofumi⁴,Nakashima Eriko³,Tachikawa Yoshimichi³,Choi Ilseung³,Taguchi Kenichi¹,Suehiro Youko³⁴

Affiliation:

1. Department of Clinical Laboratory Medicine, NHO Kyushu Cancer Center, Fukuoka, Japan

2. Medical Information Center, Kyushu University Hospital, Fukuoka, Japan

3. Department of Hematology, NHO Kyushu Cancer Center, Fukuoka, Japan

4. Department of Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan

Funder

any

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2022.2051863

Reference63 articles.

1. Bendamustine: Rebirth of an Old Drug

2. Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites

3. Bendamustine

4. Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel – an update

5. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation rule;Leukemia & Lymphoma;2022-10-11

2. Bendamustine/rituximab;Reactions Weekly;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3